Figure1 (Figure1)
Description: This is a Kaplan-Meier plot showing the progression-free survival based on BICR assessment in VERITAC-2 for patients with ESR1-mutated tumors. The plot compares the effectiveness of two treatments, "VEPPANU" and "Fulvestrant", over a duration of time measured in months. The number of patients at risk are shown below the graph for each time point.*